MARKET

XFOR

XFOR

X4 Pharmaceuticals Inc
NASDAQ
4.040
0.000
0.00%
After Hours: 4.030 -0.01 -0.25% 19:06 05/22 EDT
OPEN
4.050
PREV CLOSE
4.040
HIGH
4.195
LOW
4.000
VOLUME
177.82K
TURNOVER
--
52 WEEK HIGH
4.830
52 WEEK LOW
1.350
MARKET CAP
381.05M
P/E (TTM)
-0.8708
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XFOR last week (0511-0515)?
Weekly Report · 5d ago
Top Executive Makes a Bold Move With X4 Pharmaceuticals Stock
TipRanks · 05/14 02:01
X4 Pharmaceuticals corrects director nominee name in amended 8-K filing
PUBT · 05/13 20:58
Six new option listings on May 13th
TipRanks · 05/13 15:56
X4 Pharmaceuticals Shareholders Approve Expanded Equity Incentive Plan
TipRanks · 05/12 21:34
X4 Pharmaceuticals shareholders approved amended 2017 equity incentive plan share increase
PUBT · 05/12 20:24
Weekly Report: what happened at XFOR last week (0504-0508)?
Weekly Report · 05/11 10:07
Guggenheim Sticks to Their Buy Rating for X4 Pharmaceuticals (XFOR)
TipRanks · 05/07 11:12
More
About XFOR
X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4. It has developed a small-molecule, oral antagonists of the chemokine receptor C-X-C receptor type 4 (CXCR4). It has two pre-clinical candidates: X4P-003, a second-generation CXCR4 antagonist designed to have enhanced properties relative to mavorixafor, potentially enabling opportunities in CXCR4-dependent disorders and primary immunodeficiencies, and X4P-002, a CXCR4 antagonist with a distribution profile and a demonstrated ability to cross the blood-brain barrier.

Webull offers X4 Pharmaceuticals Inc stock information, including NASDAQ: XFOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XFOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XFOR stock methods without spending real money on the virtual paper trading platform.